Gene Expression
0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
GaldermaSculptra
GaldermaSculptra
Angeles TherapeuticsWriting about people
Clinical Trials (3)
Total enrollment: 391 patients across 3 trials
A Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™
Start: Oct 2026Est. completion: Apr 2028300 patients
N/ARecruiting
Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler
Start: Sep 2022Est. completion: Nov 202321 patients
N/ACompleted
Neural and Physiological Responses to Real-World Experiences
Start: Jan 2013Est. completion: Jan 201570 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 391 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.